Leading the way to safer medication
 Crosscheck  Recommender

Teriflunomide

Description

Teriflunomide is an immunomodulatory agent with anti-inflammatory properties that selectively and reversibly inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHO-DH), required for the de novo pyrimidine synthesis. As a consequence teriflunomide reduces the proliferation of dividing cells that need de novo synthesis of pyrimidine to expand. The exact mechanism by which teriflunomide exerts its therapeutic effect in MS is not fully understood, but this is mediated by a reduced number of lymphocytes.

ATC Classification

Code
Title
Category
L04AA31
Teriflunomide
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants

Trade names

Trade name
Countries

Australia Austria Canada Cyprus France

Australia

Australia

Product Monographs

Monograph
Type
Country
AUBAGIO Film-coated tablets
MPI, EU: SmPC